Geode Capital Management’s Insys Therapeutics, Inc. INSY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-336,136
| Closed | -$1.55M | – | 4263 |
|
|
2019
Q1 | $1.55M | Buy |
336,136
+15,822
| +5% | +$74.9K | ﹤0.01% | 2988 |
|
|
2018
Q4 | $1.12M | Buy |
320,314
+8,064
| +3% | +$56K | ﹤0.01% | 3064 |
|
|
2018
Q3 | $3.15M | Buy |
312,250
+10,502
| +3% | +$83.8K | ﹤0.01% | 2648 |
|
|
2018
Q2 | $2.18M | Buy |
301,748
+51,033
| +20% | +$356K | ﹤0.01% | 2806 |
|
|
2018
Q1 | $1.51M | Buy |
250,715
+5,050
| +2% | +$41.7K | ﹤0.01% | 2917 |
|
|
2017
Q4 | $2.36M | Sell |
245,665
-11,653
| -5% | -$76.3K | ﹤0.01% | 2654 |
|
|
2017
Q3 | $2.28M | Buy |
257,318
+5,120
| +2% | +$52.8K | ﹤0.01% | 2668 |
|
|
2017
Q2 | $3.19M | Sell |
252,198
-52,846
| -17% | -$625K | ﹤0.01% | 2450 |
|
|
2017
Q1 | $3.21M | Buy |
305,044
+26,913
| +10% | +$287K | ﹤0.01% | 2382 |
|
|
2016
Q4 | $2.56M | Buy |
278,131
+95,291
| +52% | +$1.08M | ﹤0.01% | 2494 |
|
|
2016
Q3 | $2.15M | Buy |
182,840
+839
| +0.5% | +$12.8K | ﹤0.01% | 2520 |
|
|
2016
Q2 | $2.35M | Buy |
182,001
+4,536
| +3% | +$66.1K | ﹤0.01% | 2373 |
|
|
2016
Q1 | $2.84M | Buy |
177,465
+10,861
| +7% | +$206K | ﹤0.01% | 2220 |
|
|
2015
Q4 | $4.77M | Sell |
166,604
-6,847
| -4% | -$190K | ﹤0.01% | 1908 |
|
|
2015
Q3 | $4.94M | Buy |
173,451
+25,186
| +17% | +$927K | ﹤0.01% | 1855 |
|
|
2015
Q2 | $5.33M | Buy |
148,265
+9,315
| +7% | +$290K | ﹤0.01% | 1844 |
|
|
2015
Q1 | $4.04M | Buy |
138,950
+8,974
| +7% | +$237K | ﹤0.01% | 1989 |
|
|
2014
Q4 | $2.74M | Buy |
129,976
+15,162
| +13% | +$300K | ﹤0.01% | 2233 |
|
|
2014
Q3 | $2.23M | Buy |
114,814
+23,164
| +25% | +$364K | ﹤0.01% | 2299 |
|
|
2014
Q2 | $1.43M | Sell |
91,650
-20,842
| -19% | -$337K | ﹤0.01% | 2584 |
|
|
2014
Q1 | $2.33M | Sell |
112,492
-68,789
| -38% | -$1.36M | ﹤0.01% | 2246 |
|
|
2013
Q4 | $2.34M | Buy |
181,281
+68,730
| +61% | +$953K | ﹤0.01% | 2202 |
|
|
2013
Q3 | $1.31M | Buy |
112,551
+48,210
| +75% | +$396K | ﹤0.01% | 2442 |
|
|
2013
Q2 | $297K | Buy |
+64,341
| New | +$236K | ﹤0.01% | 3090 |
|
Other funds holding INSY
WS
Geode Capital Management's INSY Position: Q2 2019 in Review
Geode Capital Management sold out of Insys Therapeutics, Inc. (INSY) in Q2 2019, closing a stake of 336,136 shares — an estimated $1.55M sold.
Geode Capital Management first reported a position in INSY in Q2 2013 and held it in 24 quarters. The position peaked at $5.33M in Q2 2015. 16 funds tracked by Wall St. Rank hold INSY as of Q2 2019.
- Geode Capital Management reported no remaining Insys Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
- Geode Capital Management sold 336,136 Insys Therapeutics, Inc. shares in Q2 2019, an estimated $1.55M.
- Geode Capital Management first reported a position in Insys Therapeutics, Inc. in Q2 2013 and held it in 24 quarters.
- Geode Capital Management's Insys Therapeutics, Inc. position peaked at $5.33M in Q2 2015.
- 16 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2019.
Based on Geode Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.